Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BY101921 plus toripalimab in advanced malignant solid tumors
CTR20250911Phase 2Active
- Sponsor
- Combi-Blocks
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BY101921 in Non-hematologic malignancy, sponsored by Combi-Blocks. Started Apr 2025; status: active.
02
Drugs
BY101921
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on CTR20250911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250911.